首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

【24h】

Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

机译：白消安与环磷酰胺和白消安与氟达拉滨作为同种异体造血干细胞移植治疗骨髓恶性肿瘤的清髓条件的比较

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2016年第1期|共1页
作者
Mori Takehiko; Ohashi Kazuteru; Kanamori Heiwa; Sakura Toru; Yano Shingo; Kanda Yoshinobu; Kako Shinichi; Tachibana Takayoshi; Yokota Akira; Onizuka Makoto; Nakaseko Chiaki; Okamoto Shinichiro;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies [J] . Mori Takehiko, Ohashi Kazuteru, Kanamori Heiwa, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：白消安与环磷酰胺和白消安与氟达拉滨作为同种异体造血干细胞移植治疗骨髓恶性肿瘤的清髓条件的比较
2. Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome [J] . Sagar S. Patel, Lisa Rybicki, Brad Pohlman, Hematology/Oncology and Stem Cell Therapy . 2020,第3期

机译：血管甘蔗/环磷酰胺对血氟甘露植物细胞移植术中急性髓性白血病和髓细胞增强综合征的对比效果
3. Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning [J] . Tang Liyuan, Wang Na, Xing Chongyun, Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2018,第期

机译：绝对单核细胞计数后移植后患者急性髓性白血病患者患者的疗效与伯磺丹和环磷酰胺调理患者进行骨髓间同种异体造血干细胞移植
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study [O] . Hui Liu, Xiao Zhai, Zhaoyang Song, 2013

机译：与白消安加环磷酰胺相比白消安加氟达拉滨是一种急性清髓治疗方案用于同种异体造血干细胞移植首次完全缓解的急性髓细胞性白血病：一项前瞻性和多中心研究
7. Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies [O] . Takehiko Mori, Kazuteru Ohashi, Heiwa Kanamori, 2016

机译：氟胺与氟胺与氟胺与氟甲兰的霉菌与霉菌性调节对骨髓恶性肿瘤同种异体造血干细胞移植的霉菌调理

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号